Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Passmore

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
International Journal of Geriatric Psychiatry|October 14, 2004
Behavioural and psychological syndromes in Alzheimer's diseaseA Mirakhur, D Craig, D J Hart, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 18, 2004
Apolipoprotein E e4 allele influences aggressive behaviour in Alzheimer's diseaseD Craig, D J Hart, K McCool, et al.
QJM : Monthly Journal of the Association of Physicians|November 13, 2001
Plasma somatostatin and gastrointestinal peptides in Alzheimer's disease and vascular dementiaC J Foy, J Ardill, D Filmore, et al.
Pharmacotherapy|July 23, 1999
Pharmaceutical care of patients with congestive heart failure: interventions and outcomesS Varma, J C McElnay, C M Hughes, et al.
European Journal of Clinical Pharmacology|January 1, 1987
The effect of chronic captopril therapy on adrenergic receptors, plasma noradrenaline and the vascular responses to infused noradrenalineG B Kondowe, S Copeland, A P Passmore, et al.
Pharmacology|October 1, 1993
A comparison of Agiolax and lactulose in elderly patients with chronic constipationA P Passmore, K W Davies, P G Flanagan, et al.
The Quarterly Journal of Medicine|November 1, 1991
The antihypertensive and metabolic effects of low and conventional dose cyclopenthiazide in type II diabetics with hypertensionA P Passmore, E M Whitehead, V Crawford, et al.
Aging & Mental Health|October 19, 2020
Anticholinergic drug use and risk of mortality for people with dementia in Northern IrelandA J McMichael, E Zafeiridi, M Ryan, et al.
QJM : Monthly Journal of the Association of Physicians|August 31, 2001
Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehydeL T McGrath, B M McGleenon, S Brennan, et al.
QJM : Monthly Journal of the Association of Physicians|April 21, 1999
Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's diseaseC J Foy, A P Passmore, M D Vahidassr, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
International Journal of Geriatric Psychiatry|October 14, 2004
Behavioural and psychological syndromes in Alzheimer's diseaseA Mirakhur, D Craig, D J Hart, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 18, 2004
Apolipoprotein E e4 allele influences aggressive behaviour in Alzheimer's diseaseD Craig, D J Hart, K McCool, et al.
QJM : Monthly Journal of the Association of Physicians|November 13, 2001
Plasma somatostatin and gastrointestinal peptides in Alzheimer's disease and vascular dementiaC J Foy, J Ardill, D Filmore, et al.
Pharmacotherapy|July 23, 1999
Pharmaceutical care of patients with congestive heart failure: interventions and outcomesS Varma, J C McElnay, C M Hughes, et al.
European Journal of Clinical Pharmacology|January 1, 1987
The effect of chronic captopril therapy on adrenergic receptors, plasma noradrenaline and the vascular responses to infused noradrenalineG B Kondowe, S Copeland, A P Passmore, et al.
Pharmacology|October 1, 1993
A comparison of Agiolax and lactulose in elderly patients with chronic constipationA P Passmore, K W Davies, P G Flanagan, et al.
The Quarterly Journal of Medicine|November 1, 1991
The antihypertensive and metabolic effects of low and conventional dose cyclopenthiazide in type II diabetics with hypertensionA P Passmore, E M Whitehead, V Crawford, et al.
Aging & Mental Health|October 19, 2020
Anticholinergic drug use and risk of mortality for people with dementia in Northern IrelandA J McMichael, E Zafeiridi, M Ryan, et al.
QJM : Monthly Journal of the Association of Physicians|August 31, 2001
Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehydeL T McGrath, B M McGleenon, S Brennan, et al.
QJM : Monthly Journal of the Association of Physicians|April 21, 1999
Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's diseaseC J Foy, A P Passmore, M D Vahidassr, et al.
Pageof 10